TY  - JOUR
AU  - Garcia-Pavia, Pablo
AU  - Grogan, Martha
AU  - Kale, Parag
AU  - Berk, John L
AU  - Maurer, Mathew S
AU  - Conceição, Isabel
AU  - Di Carli, Marcelo
AU  - Solomon, Scott D
AU  - Chen, Chongshu
AU  - Yureneva, Elena
AU  - Vest, John
AU  - Gillmore, Julian D
PY  - 2024
DO  - 10.1002/ejhf.3138
UR  - http://hdl.handle.net/20.500.12105/20361
AB  - AIMSHELIOS-A was a Phase 3, open-label study of vutrisiran, an RNA interference therapeutic, in patients with hereditary transthyretin (ATTRv) amyloidosis with polyneuropathy. This analysis evaluated vutrisiran's impact on exploratory cardiac...
LA  - eng
PB  - Wiley
KW  - Heart Failure
KW  - Amyloid Neuropathies, Familial
KW  - Polyneuropathies
KW  - Humans
KW  - Prealbumin
TI  - Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.
TY  - journal article
ER  -